Cardinal Biocraft (智衍造物)

Cardinal Biocraft is an AI-driven synthetic biology company building a biomanufacturing platform around the Yarrowia lipolytica chassis organism, combining AI-guided enzyme and strain design, artificial chromosome technology and a high-throughput automated strain construction and screening platform to cover strain development, metabolic engineering and scale-up fermentation. Its flagship product, the antioxidant astaxanthin, is commercial with orders exceeding RMB 10 million and pilot-scale production costs below conventional chemical synthesis, and the company is also developing Omega-3 (EPA/DHA) ingredients for pharmaceutical, chemical, agricultural, food and feed markets. The brand originated as a Silicon Valley startup founded in 2020 by Dr. Zeng Jijiao, a Washington State University engineering PhD with data science and machine learning backgrounds; the Chinese operating entity was incorporated in 2024 and works with the Hefei Grand Health Research Institute.

  • Seed
  • AI/ML
  • Biotechnology
  • Synthetic Biology
  • Healthcare & Life Sciences

1

Round

1

Industry

4

Tags

Nov 9, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Nov 9, 2026

    CNY 7.5M

    Seed

    Led by Hefei Life and Health Company (合肥市生命健康公司)

    • Shenzhen Capital Group
    • Jinqiao Fund (金桥基金)
    • Greater Bay Area Venture Capital Guiding Fund (粤港澳大湾区创业投资引导基金)
    • Hefei Life and Health Company (合肥市生命健康公司)
    • Chantou Guozheng (产投国正)
    • Shanghai Rongquan Yuanji (上海榕泉元吉)
    • Guannan Equity Fund (灌南股权基金)
    • Guannan Talent Fund (灌南人才基金)

    Article coming soon.

Pricing

Research Cardinal Biocraft (智衍造物) — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if Cardinal Biocraft (智衍造物) is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational